{"id":"https://openalex.org/W612583348","doi":"https://doi.org/10.1182/blood.v124.21.3094.3094","title":"A Phase I Study of 177 lu-DOTA-HH1 (Betalutin) Radioimmunotherapy for Patients with Relapsed CD37+ Non-Hodgkin's B Cell Lymphoma","display_name":"A Phase I Study of 177 lu-DOTA-HH1 (Betalutin) Radioimmunotherapy for Patients with Relapsed CD37+ Non-Hodgkin's B Cell Lymphoma","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W612583348","doi":"https://doi.org/10.1182/blood.v124.21.3094.3094","mag":"612583348"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.3094.3094","doi":"https://doi.org/10.1182/blood.v124.21.3094.3094","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.3094.3094","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090605318","display_name":"Arne Kolstad","orcid":"https://orcid.org/0000-0003-2699-3357","observed_orcids":["https://orcid.org/0000-0003-2699-3357"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Arne Kolstad","raw_affiliation_strings":["Oslo University Hospital, Oslo, Norway","Oslo University Hospital, Radiumhospitalet, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"Oslo University Hospital, Radiumhospitalet, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045812810","display_name":"Ulf Erik Madsbu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Ulf Madsbu","raw_affiliation_strings":["Oslo University Hospital, Radiumhospitalet, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Radiumhospitalet, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079375927","display_name":"Jostein Dahle","orcid":"https://orcid.org/0000-0002-1447-6005","observed_orcids":["https://orcid.org/0000-0002-1447-6005"]},"institutions":[{"id":"https://openalex.org/I4210091095","display_name":"Nordic Nanovector (Norway)","ror":"https://ror.org/00a1z4k38","country_code":"NO","type":"company","lineage":["https://openalex.org/I4210091095"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Jostein Dahle","raw_affiliation_strings":["Nordic Nanovector AS, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nordic Nanovector AS, Oslo, Norway","institution_ids":["https://openalex.org/I4210091095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035282867","display_name":"Caroline Stokke","orcid":"https://orcid.org/0000-0003-4465-9635","observed_orcids":["https://orcid.org/0000-0003-4465-9635"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Caroline Stokke","raw_affiliation_strings":["Oslo University Hospital, Ullev\u00e5l, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Ullev\u00e5l, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074208071","display_name":"Tore Bach\u2010Gansmo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Tore Bach-Gansmo","raw_affiliation_strings":["Oslo University Hospital, Ullev\u00e5l, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Ullev\u00e5l, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025920921","display_name":"Ayca Muftuler L\u00f8ndalen","orcid":"https://orcid.org/0000-0002-0137-9214","observed_orcids":["https://orcid.org/0000-0002-0137-9214"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Ayca Muftuler L\u00f8ndalen","raw_affiliation_strings":["Oslo University Hospital, Radiumhospitalet, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Radiumhospitalet, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070831538","display_name":"Jon Erik Holtedahl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Jon Erik Holtedahl","raw_affiliation_strings":["Oslo University Hospital, Ullev\u00e5l, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Ullev\u00e5l, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113366921","display_name":"Mona Elisabeth Revheim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Mona Elisabeth Revheim","raw_affiliation_strings":["Oslo University Hospital, Radiumhospitalet, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Radiumhospitalet, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035939033","display_name":"\u00d8yvind Sverre Bruland","orcid":"https://orcid.org/0000-0003-1631-3733","observed_orcids":["https://orcid.org/0000-0003-1631-3733","https://orcid.org/0009-0006-7985-9919"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"\u00d8yvind Bruland","raw_affiliation_strings":["Oslo University Hospital, Radiumhospitalet, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Radiumhospitalet, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014460763","display_name":"B. Bolstad","orcid":"https://orcid.org/0009-0007-9064-932X","observed_orcids":["https://orcid.org/0009-0007-9064-932X"]},"institutions":[{"id":"https://openalex.org/I4210091095","display_name":"Nordic Nanovector (Norway)","ror":"https://ror.org/00a1z4k38","country_code":"NO","type":"company","lineage":["https://openalex.org/I4210091095"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Bj\u00f8rg Bolstad","raw_affiliation_strings":["Nordic Nanovector AS, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nordic Nanovector AS, Oslo, Norway","institution_ids":["https://openalex.org/I4210091095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077936932","display_name":"Nils Bolstad","orcid":"https://orcid.org/0000-0003-3633-8428","observed_orcids":["https://orcid.org/0000-0003-3633-8428"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Nils Bolstad","raw_affiliation_strings":["Oslo University Hospital, Radiumhospitalet, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Radiumhospitalet, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023623204","display_name":"Anne Maria Tierens","orcid":"https://orcid.org/0000-0002-5350-8313","observed_orcids":["https://orcid.org/0000-0002-5350-8313"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Tierens","raw_affiliation_strings":["Department of Pathobiology and Laboratory Medicine, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathobiology and Laboratory Medicine, Toronto, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005283403","display_name":"Roy H. Larsen","orcid":"https://orcid.org/0000-0002-9295-7656","observed_orcids":["https://orcid.org/0000-0002-9295-7656"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Roy Hartvig Larsen","raw_affiliation_strings":["Sciencons, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sciencons, Oslo, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077973932","display_name":"Jan Alan Alfheim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091095","display_name":"Nordic Nanovector (Norway)","ror":"https://ror.org/00a1z4k38","country_code":"NO","type":"company","lineage":["https://openalex.org/I4210091095"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Jan Alan Alfheim","raw_affiliation_strings":["Nordic Nanovector AS, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nordic Nanovector AS, Oslo, Norway","institution_ids":["https://openalex.org/I4210091095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081888684","display_name":"Jan Delabie","orcid":"https://orcid.org/0000-0001-5023-0689","observed_orcids":["https://orcid.org/0000-0001-5023-0689"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA","NO"],"is_corresponding":true,"raw_author_name":"Jan Delabie","raw_affiliation_strings":["Oslo University Hospital, Radiumhospitalet, Oslo, Norway","University of Toronto, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Radiumhospitalet, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043454437","display_name":"Signe Spetalen","orcid":"https://orcid.org/0000-0002-2426-5316","observed_orcids":["https://orcid.org/0000-0002-2426-5316"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Spetalen Signe","raw_affiliation_strings":["Oslo University Hospital, Radiumhospitalet, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Radiumhospitalet, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073127696","display_name":"Martin Erlanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099621","display_name":"University Hospital of Ume\u00e5","ror":"https://ror.org/012k96e85","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210099621"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Martin Erlanson","raw_affiliation_strings":["Norrland University Hospital, Ume\u00e5, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norrland University Hospital, Ume\u00e5, Sweden","institution_ids":["https://openalex.org/I4210099621"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034692889","display_name":"Stine Nygaard Rud\u00e5","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Stine Nygaard Rud\u00e5","raw_affiliation_strings":["Oslo University Hospital, Radiumhospitalet, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Radiumhospitalet, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088720489","display_name":"Harald Holte","orcid":"https://orcid.org/0000-0001-9799-9428","observed_orcids":["https://orcid.org/0000-0001-9799-9428"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Harald Holte","raw_affiliation_strings":["Oslo University Hospital, Radiumhospitalet, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Radiumhospitalet, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5005283403","https://openalex.org/A5014460763","https://openalex.org/A5025920921","https://openalex.org/A5034692889","https://openalex.org/A5035282867","https://openalex.org/A5035939033","https://openalex.org/A5043454437","https://openalex.org/A5045812810","https://openalex.org/A5070831538","https://openalex.org/A5073127696","https://openalex.org/A5074208071","https://openalex.org/A5077936932","https://openalex.org/A5077973932","https://openalex.org/A5079375927","https://openalex.org/A5081888684","https://openalex.org/A5090605318","https://openalex.org/A5113366921"],"corresponding_institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I185261750","https://openalex.org/I4210091095","https://openalex.org/I4210099621"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.222,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.5415093,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"124","issue":"21","first_page":"3094","last_page":"3094"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.019999999552965164,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.9610000252723694},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7739999890327454},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.675000011920929},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.6200000047683716},{"id":"https://openalex.org/keywords/small-lymphocytic-lymphoma","display_name":"small lymphocytic lymphoma","score":0.7269999980926514},{"id":"https://openalex.org/keywords/marginal-zone-lymphoma","display_name":"marginal zone lymphoma","score":0.8309999704360962},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9330000281333923},{"id":"https://openalex.org/keywords/lymphoplasmacytic-lymphoma","display_name":"lymphoplasmacytic lymphoma","score":0.8859999775886536}],"concepts":[{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.9099822044372559},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6369787454605103},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.4742005467414856},{"id":"https://openalex.org/C2779931791","wikidata":"https://www.wikidata.org/wiki/Q161515","display_name":"DOTA","level":3,"score":0.47269535064697266},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.45645496249198914},{"id":"https://openalex.org/C2778476748","wikidata":"https://www.wikidata.org/wiki/Q1138590","display_name":"Non-Hodgkin's lymphoma","level":3,"score":0.426542729139328},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.42090246081352234},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4107975959777832},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39245668053627014},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.3110680878162384},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29428350925445557},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.28025344014167786},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.27513107657432556},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26040542125701904},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12193599343299866},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.3094.3094","doi":"https://doi.org/10.1182/blood.v124.21.3094.3094","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.3094.3094","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2588619042","https://openalex.org/W2487586966","https://openalex.org/W2769978855","https://openalex.org/W2074415087","https://openalex.org/W2898960368","https://openalex.org/W7126435902","https://openalex.org/W4283332672","https://openalex.org/W2565608770","https://openalex.org/W2772443625","https://openalex.org/W2769313932"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"and":[2,17,97,128,149,159,196,254,264,280,286,338,373,393,432,437,508,528,544,606,627],"aim:":[3],"The":[4,328,395,559],"CD37":[5,213,639],"antigen":[6,27,640],"is":[7,42,69,77,477,611,641],"expressed":[8],"at":[9,83,451,488,501,601],"high":[10],"levels":[11],"predominantly":[12],"by":[13,216,249,260],"normal":[14,177],"B":[15,178],"cells":[16,179],"the":[18,54,72,84,121,171,202,217,239,275,291,321,410,417,473,616,619,638],"majority":[19],"of":[20,35,53,100,140,186,189,208,247,269,278,331,341,375,386,402,434,518,537,576,623,657,685,707,729],"malignant":[21],"B-cell":[22,36,102],"lymphomas.":[23],"Hence,":[24],"this":[25,489,564,624],"surface":[26],"represents":[28],"an":[29,573,654,682,704,726],"interesting":[30],"therapeutic":[31],"target":[32],"for":[33,168,245,296,300,363,430,618],"treatment":[34,352,487],"non-Hodgkin":[37],"lymphomas":[38,103,152],"(NHL).":[39],"177Lu-DOTA-HH1":[40,580,636],"(Betalutin\u2122)":[41],"a":[43,80,110,183,205,221,383,399,541,547,582,588,642],"novel":[44],"anti-CD37":[45],"radioimmunoconjugate":[46,218],"currently":[47,483,612],"under":[48],"clinical":[49,496],"development.":[50],"Betalutin\u2122":[51,76],"consists":[52],"\u03b2-emitting":[55],"isotope":[56],"Lutetium-177":[57],"(t/2":[58],"=":[59],"6.7":[60],"days)":[61],"chelated":[62],"to":[63,71,119,129,175,274,318,348,406,409,428,494,614],"DOTA":[64],"(a":[65],"chemical":[66],"linker)":[67],"which":[68],"conjugated":[70],"murine":[73],"mAb":[74],"HH1.":[75],"delivered":[78],"in":[79,98,104,117,170,288,325,446,484,563,569,581],"ready-to-use":[81,585],"formulation":[82,586],"study":[85,113,322,411,565],"centers.":[86],"Pre-clinical":[87],"studies":[88],"have":[89,314,498,630],"demonstrated":[90],"significant":[91],"anti-tumor":[92],"activity;":[93],"both":[94,502],"ex":[95],"vivo":[96],"models":[99],"human":[101],"mice.":[105],"Based":[106,471],"on":[107,193,472,653,681,703,725],"these":[108,376,415],"results,":[109],"phase":[111,620],"I":[112],"has":[114,566,587],"been":[115,315,499,568,631],"initiated":[116,324],"order":[118,174],"determine":[120],"maximum":[122],"tolerated":[123],"dose":[124,230,452,490,503,551,584,602,607],"(MTD),":[125],"overall":[126],"safety":[127,590],"explore":[130],"tumor":[131],"response.":[132],"Methods:":[133],"Patients":[134,242],"with":[135,153,160,235,290,353,382,391,425,457,572,593],"relapsed":[136],"incurable":[137],"CD37+":[138],"NHL":[139],"follicular":[141,309],"grade":[142,458],"I-IIIA,":[143],"marginal":[144],"zone,":[145],"mantle":[146,311],"cell,":[147],"lymphoplasmacytic":[148],"small":[150],"lymphocytic":[151],"<":[154],"25%":[155],"bone":[156,265],"marrow":[157,266],"infiltration":[158],"platelet":[161,371],"counts":[162],"\u2265":[163],"150":[164],"x109/l":[165],"were":[166,243,284,334,361,421],"eligible":[167],"inclusion":[169],"study.":[172],"In":[173],"deplete":[176],"patients":[180,203,307,343,367,377,449,467,481,520,539],"first":[181,560],"received":[182,204],"pre-treatment":[184],"consisting":[185],"single":[187,356,583],"infusions":[188],"rituximab":[190,354],"(375":[191],"mg/m2)":[192],"day":[194,197,200],"1":[195,505],"8.":[198],"On":[199],"29":[201],"pre-dose":[206],"infusion":[207],"HH1":[209],"(50":[210],"mg,":[211],"cold":[212],"antibody)":[214],"followed":[215],"177Lu-DOTA-HH1administered":[219],"as":[220,238,355,423,596],"10":[222,236,514],"minute":[223],"iv":[224],"bolus.":[225],"A":[226,304],"3":[227,229],"x":[228],"escalation":[231],"design":[232],"was":[233,258,271,323,398,444,599],"used":[234],"MBq/kg":[237,534,554,610],"starting":[240],"level.":[241,491],"assessed":[244],"distribution":[246],"radioactivity":[248],"gamma":[250],"camera":[251],"wholebody":[252],"scans":[253],"SPECT/CT.":[255],"Clinical":[256],"response":[257,270],"studied":[259],"18F-FDG":[261],"PET/CT,":[262],"CT":[263],"specimens.":[267],"Evaluation":[268],"performed":[272],"according":[273,317],"NCI":[276,292],"criteria":[277],"1999":[279],"2007.":[281],"Adverse":[282,297],"events":[283,360],"monitored":[285],"scored":[287],"agreement":[289],"Common":[293],"Terminology":[294],"Criteria":[295],"Events":[298],"(CTCAE)":[299],"toxicity":[301,442],"grading.":[302],"Results:":[303],"total":[305],"often":[306],"(9":[308],"lymphoma,1":[310],"cell":[312],"lymphoma)":[313],"treated":[316,450,562],"protocol":[319],"since":[320],"December":[326],"2012.":[327],"median":[329,426],"number":[330],"prior":[332],"therapies":[333],"2":[335,454,509],"(range":[336],"1-7)":[337],"four":[339,364,519],"out":[340,517,536],"ten":[342],"had":[344,378,521,525,546],"previously":[345],"not":[346],"responded":[347],"or":[349,659,687,709,731],"progressed":[350],"during":[351],"agent.":[357],"Serious":[358],"adverse":[359],"reported":[362],"patients.":[365],"Two":[366],"developed":[368,468],"thrombocytopenia":[369],"requiring":[370],"transfusions":[372],"one":[374,524,529,545],"epistaxis.":[379],"Another":[380],"patient":[381,561],"previous":[384],"history":[385],"pulmonary":[387],"embolism":[388],"(PI)":[389],"presented":[390],"pneumonia":[392],"PI.":[394],"fourth":[396],"SAE":[397],"transient":[400],"case":[401],"atrial":[403],"fibrillation,":[404],"unlikely":[405],"be":[407,615],"related":[408],"drug.":[412],"Apart":[413],"from":[414],"events,":[416],"most":[418],"common":[419],"toxicities":[420,595],"hematological,":[422],"expected":[424],"time":[427,575],"nadir":[429],"platelets":[431],"neutrophils":[433],"39":[435],"days":[436],"48":[438],"days,":[439],"respectively.":[440],"Dose-limiting":[441],"(DLT)":[443],"observed":[445,500,600,632],"all":[447,463],"three":[448,480,538],"level":[453,504,513,532,552,603,608],"(20":[455,510],"MBq/kg),":[456],"III/IV":[459],"neutropenia":[460],"and/or":[461],"thrombocytopenia,":[462],"reversible.":[464],"However,":[465],"no":[466],"neutropenic":[469],"fever.":[470],"assumption":[474],"that":[475],"MTD":[476,617],"15":[478,553,609],"MBq/kg,":[479,515,605],"are":[482,557],"follow-up":[485],"after":[486],"With":[492],"regard":[493],"efficacy,":[495],"responses":[497,629],"(10":[506],"MBq/kg)":[507],"MBq/kg).":[511],"At":[512,531,550],"two":[516,535],"partial":[522,548,628],"remissions,":[523],"stable":[526,570],"disease":[527],"progressed.":[530],"20":[533,604],"obtained":[540],"complete":[542],"remission":[543,571],"remission.":[549],"efficacy":[555],"results":[556],"pending.":[558],"now":[567],"observation":[574],"18":[577],"months.":[578],"Conclusion:":[579],"favorable":[589],"profile,":[591],"mostly":[592],"hematological":[594],"expected.":[597],"DLT":[598],"predicted":[613],"II":[621],"part":[622],"trial.":[625],"Complete":[626],"so":[633],"far,":[634],"hence,":[635],"targeting":[637],"promising":[643],"new":[644],"candidate":[645],"against":[646],"NHL.":[647],"Disclosures":[648],"Kolstad:":[649],"Nordic":[650],"Nanovector:":[651],"Membership":[652,680,702,724],"entity's":[655,683,705,727],"Board":[656,684,706,728],"Directors":[658,686,708,730],"advisory":[660,688,710,732],"committees,":[661,711],"Research":[662],"Funding.":[663],"Dahle:Nordic":[664],"Nanovector":[665,674,691,697,716,722],"AS:":[666,675,692,698,723],"Employment,":[667,693,718],"Equity":[668,677,694,700,719],"Ownership,":[669,678,701],"Patents":[670,712],"&":[671,713],"Royalties.":[672,714],"Bruland:Nordic":[673],"Consultancy,":[676,699],"Honoraria,":[679],"committees.":[689,733],"Bolstad:Nordic":[690],"Ownership.":[695,720],"Larsen:Nordic":[696],"Alfheim:Nordic":[715],"as:":[717],"Holte:Nordic":[721]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}